Stanley Druckenmiller
WVE icon

Stanley Druckenmiller’s Wave Life Sciences WVE Stock Holding History

Stanley Druckenmiller’s Portfolio WVE Stock Details WVE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.25M Hold
173,000
– – 0.04% 70
2025
Q4 		$2.94M Buy
+173,000
New +$1.76M 0.07% 61

Other funds holding WVE

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
GP
GSK plc London $599M AUM
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MC
Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Stanley Druckenmiller's WVE Position: Q1 2026 in Review

Stanley Druckenmiller held its Wave Life Sciences (WVE) position steady in Q1 2026 at 173,000 shares worth $1.25M. The position accounts for 0.04% of the portfolio, ranked #70.

Stanley Druckenmiller first reported a position in WVE in Q4 2025 and has held it in 2 quarters since. The position peaked at $2.94M in Q4 2025. 230 funds tracked by Wall St. Rank hold WVE as of Q1 2026.

  • Stanley Druckenmiller held 173,000 shares of Wave Life Sciences worth $1.25M as of Q1 2026.
  • Stanley Druckenmiller left its Wave Life Sciences share count unchanged in Q1 2026.
  • Wave Life Sciences made up 0.04% of Stanley Druckenmiller's portfolio in Q1 2026, its #70 holding.
  • Stanley Druckenmiller first reported a position in Wave Life Sciences in Q4 2025 and has held it in 2 quarters since.
  • Stanley Druckenmiller's Wave Life Sciences position peaked at $2.94M in Q4 2025.
  • 230 funds tracked by Wall St. Rank held Wave Life Sciences as of Q1 2026.

Based on Duquesne Family Office's 13F filing for Q1 2026, filed 15 May 2026.